FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Flair Writing IPO and Mukka Proteins IPO.
Flair Writing IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Mukka Proteins IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Flair Writing IPO | Mukka Proteins IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Nuvama Wealth Management Limited Axis Capital Limited |
Fedex Securities Pvt Ltd |
Registrar | Link Intime India Private Ltd | Cameo Corporate Services Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Flair Writing IPO is up to ₹593.00 Cr whereas the issue size of the Mukka Proteins IPO is up to ₹224.00 Cr. The final issue price of Flair Writing IPO is ₹304.00 per share and of Mukka Proteins IPO is ₹28.00 per share.
Flair Writing IPO | Mukka Proteins IPO | |
---|---|---|
Face Value | ₹5 per share | ₹1 per share |
Issue Price (Lower) | ₹288.00 per share | ₹26.00 per share |
Issue Price (Upper) | ₹304.00 per share | ₹28.00 per share |
Issue Price (Final) | ₹304.00 per share | ₹28.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 49 shares | 535 shares |
Fresh Issue Size | 96,05,263 shares | 8,00,00,000 shares |
Fresh Issue Size (Amount) | up to ₹292.00 Cr | up to ₹224.00 Cr |
OFS Issue Size | 99,01,315 shares | |
OFS Issue Size (Amount) | up to ₹301.00 Cr | |
Issue Size Total | 1,95,06,578 shares | 8,00,00,000 shares |
Issue Size Total (Amount) | up to ₹593.00 Cr | up to ₹224.00 Cr |
Flair Writing IPO opens on Nov 22, 2023, while Mukka Proteins IPO opens on Feb 29, 2024. The closing date of Flair Writing IPO and Mukka Proteins IPO is Nov 24, 2023, and Mar 04, 2024, respectively.
Flair Writing IPO | Mukka Proteins IPO | |
---|---|---|
Anchor Bid Date | Nov 21, 2023 | Feb 28, 2024 |
Issue Open | Nov 22, 2023 | Feb 29, 2024 |
Issue Close | Nov 24, 2023 | Mar 04, 2024 |
Basis Of Allotment (Tentative) | Nov 29, 2023 | Mar 05, 2024 |
Initiation of Refunds (Tentative) | Nov 30, 2023 | Mar 06, 2024 |
Credit of Share (Tentative) | Nov 30, 2023 | Mar 06, 2024 |
Listing date (Tentative) | Dec 01, 2023 | Mar 07, 2024 |
Anchor Lockin End date 1 | Dec 29, 2023 | Apr 04, 2024 |
Anchor Lockin End date 2 | Feb 27, 2024 | Jun 03, 2024 |
Flair Writing IPO P/E ratio is 23.36, as compared to Mukka Proteins IPO P/E ratio of 12.96.
Flair Writing IPO | Mukka Proteins IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Flair Writing Industries Limited Financial Information (Restated Consolidated)Flair Writing Industries Limited's revenue increased by 62.39% and profit after tax (PAT) rose by 114.14% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Mukka Proteins Limited Financial Information (Restated Consolidated)Mukka Proteins Limited's revenue increased by 52.52% and profit after tax (PAT) rose by 84.07% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 97.49% | 100% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 79.21% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 23.36 | 12.96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹3204.00 Cr. | ₹840.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 31.17%% | 36.71%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 31.24%% | 17.62%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.26 | 1.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹12.33 | ₹2.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 31.17%% | 34.19%% |
In the Flair Writing IPO retail investors (RII) are offered 68,27,302 shares while in Mukka Proteins IPO retail investors are offered 68,27,302 shares. Qualified institutional buyers (QIB) are offered 39,01,316 shares in Flair Writing IPO and 1,60,00,435 shares in Mukka Proteins IPO.
Flair Writing IPO | Mukka Proteins IPO | |
---|---|---|
Anchor Investor Reserveration | 58,51,972 shares | 2,39,99,565 shares |
Market Maker Reserveration | ||
QIB | 39,01,316 shares | 1,60,00,435 shares |
NII | 29,25,987 shares | 1,20,00,000 shares |
RII | 68,27,302 shares | 2,80,00,000 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 1,36,54,605 shares | 5,60,00,435 shares |
Flair Writing IPO subscribed 49.28x in total, whereas Mukka Proteins IPO subscribed 136.99x.
Flair Writing IPO | Mukka Proteins IPO | |
---|---|---|
QIB (times) | 122.02x | 189.28x |
NII (times) | 35.23x | 250.39x |
Big NII (times) | 36.53x | 254.15x |
Small NII (times) | 32.61x | 242.86x |
RII (times) | 13.73x | 58.52x |
Employee (times) | ||
Other (times) | ||
Total (times) | 49.28x | 136.99x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|